Ambassador Pyatt’s Remarks at the Hellenic American Chamber of Commerce HealthWorld Conference 2021

Ambassador Pyatt: "As Greece continues to distinguish itself as a forward-leaning, innovation- and investment-friendly market for healthcare companies, I know that more of America’s leading pharmaceutical, medical device, and technology companies will take notice and begin to call Greece home, just as Pfizer has done with its significant new investment in Thessaloniki." Read More»

Ambassador Pyatt’s Remarks at AmCham HealthWorld Conference 2020 

Ambassador Pyatt: "Greece’s performance over the past several months has won praise from partners and media around the world, and the government has continued to make investments to strengthen the healthcare system, including increased staffing, ICU capacity, and social support.  Until a vaccine is developed, this is our world.  We must continue to act responsibly, ... Read More»

Ambassador Pyatt’s Remarks at AmCham HealthWorld Conference 2019

The pharmaceutical industry remains a pillar for investment in Greece through expenditure on research and development for new therapies.  As of 2017, a total of 2,265 clinical trials brought up to 80 million euros in foreign investment to Greece.  American pharmaceutical companies have told me that the potential market could be much larger if the ... Read More»

Ambassador Pyatt’s Remarks at Healthworld Forum 2018

U.S. companies have a great deal of experience in other countries and in a variety of healthcare markets. They could be good partners, providing advice before decisions are made that might have any negative impact on the market. They could offer help in the effort to encourage increased investments in Greece’s healthcare sector and ensure ... Read More»
Show More ∨